BJR
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
British Journal of Radiology (2003) 76, 32-38
© 2003 British Institute of Radiology
doi: 10.1259/bjr/33961719
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vano, E
Right arrow Articles by Galvan, C
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vano, E
Right arrow Articles by Galvan, C

Full Paper

Skin dose and dose–area product values in patients undergoing intracoronary brachytherapy

E Vano1,4, C Prieto1, J M Fernandez1,4, L Gonzalez4, M Sabate2 and C Galvan3,4

1 Medical Physics Service and 2 Interventional Cardiology Service and 3 Radiothereapy Service, San Carlos University Hospital, 28040 Madrid, Spain and 4 Radiology Department, Medicine School, Complutense University, 28040 Madrid, Spain

Entrance skin doses, dose–area product (DAP) values, fluoroscopy times and digital cine acquisition data were measured for 86 patients undergoing intracoronary brachytherapy procedures with beta sources, to estimate risk of skin injuries. Interventions were carried out in three dedicated X-ray interventional cardiology rooms equipped with X-ray systems operating in pulsed modes, with high filtration and edge filter options. Skin dose distribution was analysed in detail in 56 patients using slow films and thermoluminescent dosimetry. Digital recording of Digital Imaging and Communications in Medicine cine images also allowed analysis of the technical parameters used throughout the procedures. A protocol for clinical follow-up of these patients at the cardiology service is also presented, which prescribes special attention when a threshold dose is reached. Median values for DAP, fluoroscopy time and number of frames were 81.2 Gy cm2, 17.5 min and 1569 frames, respectively, and maximum values were 323.3 Gy cm2, 46.2 min and 3213 frames, respectively. In two cases, maximum skin doses in a procedure reached 3.5 Gy and 4.6 Gy. Comparing median values in this study, intracoronary brachytherapy involved approximately two-fold the DAP used in percutaneous transluminal coronary angioplasty procedures performed during the same period in the same catheterization laboratories, as a consequence of the need to monitor the radioactive source location used for the treatment of stenoses and the intravascular ultrasound. Special care must be paid in those cases of high dose in relation to potential patient skin injuries and late effects.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
BJR DMFR IMAGING  ALL BIR JOURNALS 
Copyright © 2003 by the British Institute of Radiology.